Nisa Investment Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$32.7K Sell
1,517
-204
-12% -$4.4K ﹤0.01% 1728
2025
Q1
$28.6K Hold
1,721
﹤0.01% 1753
2024
Q4
$31.6K Buy
1,721
+136
+9% +$2.5K ﹤0.01% 1798
2024
Q3
$24.4K Buy
1,585
+257
+19% +$3.95K ﹤0.01% 1846
2024
Q2
$21.6K Sell
1,328
-662
-33% -$10.8K ﹤0.01% 1912
2024
Q1
$36.8K Buy
1,990
+70
+4% +$1.29K ﹤0.01% 1728
2023
Q4
$60.1K Sell
1,920
-1,200
-38% -$37.6K ﹤0.01% 1594
2023
Q3
$65K Hold
3,120
﹤0.01% 1653
2023
Q2
$74.7K Hold
3,120
﹤0.01% 1602
2023
Q1
$59K Buy
3,120
+1,960
+169% +$37.1K ﹤0.01% 1661
2022
Q4
$18K Buy
1,160
+24
+2% +$372 ﹤0.01% 2077
2022
Q3
$18K Sell
1,136
-331
-23% -$5.25K ﹤0.01% 2072
2022
Q2
$21K Sell
1,467
-4,800
-77% -$68.7K ﹤0.01% 2032
2022
Q1
$152K Buy
+6,267
New +$152K ﹤0.01% 1485
2021
Q4
Sell
-13,648
Closed -$227 2145
2021
Q3
$227 Sell
13,648
-953
-7% -$16 ﹤0.01% 1359
2021
Q2
$356 Buy
14,601
+3,510
+32% +$86 ﹤0.01% 1229
2021
Q1
$286 Hold
11,091
﹤0.01% 1359
2020
Q4
$593K Buy
11,091
+6,919
+166% +$370K ﹤0.01% 1110
2020
Q3
$172K Sell
4,172
-2,096
-33% -$86.4K ﹤0.01% 1355
2020
Q2
$304K Buy
6,268
+86
+1% +$4.17K ﹤0.01% 1184
2020
Q1
$261K Buy
6,182
+110
+2% +$4.64K ﹤0.01% 1119
2019
Q4
$260K Buy
6,072
+3,402
+127% +$146K ﹤0.01% 1265
2019
Q3
$96K Buy
2,670
+170
+7% +$6.11K ﹤0.01% 1464
2019
Q2
$67K Hold
2,500
﹤0.01% 1468
2019
Q1
$67K Hold
2,500
﹤0.01% 1496
2018
Q4
$40K Hold
2,500
﹤0.01% 1471
2018
Q3
$52K Sell
2,500
-1,500
-38% -$31.2K ﹤0.01% 1466
2018
Q2
$61K Buy
4,000
+2,600
+186% +$39.7K ﹤0.01% 1424
2018
Q1
$31K Hold
1,400
﹤0.01% 1460
2017
Q4
$42K Sell
1,400
-510
-27% -$15.3K ﹤0.01% 1467
2017
Q3
$72K Hold
1,910
﹤0.01% 1414
2017
Q2
$53K Sell
1,910
-2,600
-58% -$72.1K ﹤0.01% 1401
2017
Q1
$155K Buy
4,510
+510
+13% +$17.5K ﹤0.01% 1298
2016
Q4
$115K Buy
4,000
+3,000
+300% +$86.3K ﹤0.01% 1329
2016
Q3
$32K Hold
1,000
﹤0.01% 1496
2016
Q2
$32K Hold
1,000
﹤0.01% 1466
2016
Q1
$28K Buy
+1,000
New +$28K ﹤0.01% 1492